Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

Antivir Ther. 2009;14(1):75-83.

PMID:
19320239
[PubMed - indexed for MEDLINE]
2.

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis.

Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Renaud-Théry F, Shaffer N, Hargreaves S, Mills EJ, Ford N.

AIDS. 2013 Jun 1;27(9):1403-12. doi: 10.1097/QAD.0b013e32835f1db0. Review.

PMID:
23343913
[PubMed - indexed for MEDLINE]
3.

A systematic review of the psychiatric side-effects of efavirenz.

Kenedi CA, Goforth HW.

AIDS Behav. 2011 Nov;15(8):1803-18. doi: 10.1007/s10461-011-9939-5. Review.

PMID:
21484283
[PubMed - indexed for MEDLINE]
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk